Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 400

1.

CDP-choline: pharmacological and clinical review.

Secades JJ, Frontera G.

Methods Find Exp Clin Pharmacol. 1995 Oct;17 Suppl B:1-54. Review.

PMID:
8709678
2.

Citicoline: pharmacological and clinical review, 2006 update.

Secades JJ, Lorenzo JL.

Methods Find Exp Clin Pharmacol. 2006 Sep;28 Suppl B:1-56. Review.

PMID:
17171187
3.
4.

Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.

Alvarez XA, Mouzo R, Pichel V, Pérez P, Laredo M, Fernández-Novoa L, Corzo L, Zas R, Alcaraz M, Secades JJ, Lozano R, Cacabelos R.

Methods Find Exp Clin Pharmacol. 1999 Nov;21(9):633-44.

PMID:
10669911
5.
10.

"Brain-specific" nutrients: a memory cure?

McDaniel MA, Maier SF, Einstein GO.

Nutrition. 2003 Nov-Dec;19(11-12):957-75. Review.

PMID:
14624946
11.

Efficacy of CDP-choline in the treatment of senile alterations in memory.

de la Morena E.

Ann N Y Acad Sci. 1991;640:233-6.

PMID:
1776744
12.

Efficacy of citicoline as an acute stroke treatment.

Clark WM.

Expert Opin Pharmacother. 2009 Apr;10(5):839-46. doi: 10.1517/17460440902835475 .

PMID:
19351232
13.

Membrane stabilizer: citicoline.

Zweifler RM.

Curr Med Res Opin. 2002;18 Suppl 2:s14-7. Review.

PMID:
12365823
14.

Neuroprotective effects of citidine-5-diphosphocholine on impaired spatial memory in a rat model of cerebrovascular dementia.

Takasaki K, Uchida K, Fujikawa R, Nogami A, Nakamura K, Kawasaki C, Yamaguchi K, Morita M, Morishita K, Kubota K, Katsurabayashi S, Mishima K, Fujiwara M, Iwasaki K.

J Pharmacol Sci. 2011;116(2):232-7. Epub 2011 May 25.

15.

Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease.

Franco-Maside A, Caamaño J, Gómez MJ, Cacabelos R.

Methods Find Exp Clin Pharmacol. 1994 Oct;16(8):597-607.

PMID:
7760585
16.

A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke.

Hurtado O, Cárdenas A, Pradillo JM, Morales JR, Ortego F, Sobrino T, Castillo J, Moro MA, Lizasoain I.

Neurobiol Dis. 2007 Apr;26(1):105-11. Epub 2007 Jan 16.

PMID:
17234423
17.

Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?

Parnetti L, Mignini F, Tomassoni D, Traini E, Amenta F.

J Neurol Sci. 2007 Jun 15;257(1-2):264-9. Epub 2007 Feb 28. Review.

PMID:
17331541
18.

CDP-choline reduces severity of intestinal injury in a neonatal rat model of necrotizing enterocolitis.

Cetinkaya M, Cansev M, Cekmez F, Tayman C, Canpolat FE, Kafa IM, Uysal S, Tunc T, Sarici SU.

J Surg Res. 2013 Jul;183(1):119-28. doi: 10.1016/j.jss.2012.11.032. Epub 2012 Dec 5.

PMID:
23228325
19.

Citicoline, use in cognitive decline: vascular and degenerative.

García-Cobos R, Frank-García A, Gutiérrez-Fernández M, Díez-Tejedor E.

J Neurol Sci. 2010 Dec 15;299(1-2):188-92. doi: 10.1016/j.jns.2010.08.027. Epub 2010 Sep 27. Review.

PMID:
20875651
20.

Citicoline for treatment of experimental focal ischemia: histologic and behavioral outcome.

Aronowski J, Strong R, Grotta JC.

Neurol Res. 1996 Dec;18(6):570-4.

PMID:
8985961

Supplemental Content

Support Center